CR2 and rheumatoid arthritis: Furthermore, IHC analysis revealed that PsA and Abneg RA patients had comparable levels of CD21+ cells (0.72 ± 0.79 vs 0.60 ± 0.95; p = 0.18 respectively) regardless of the treatment scheme (Fig. 1a–d).